Tag Archives: FDA

Approval of Avastin in Breast Cancer Revoked

The New York Times, November 18, reports the Food and Drug Administration has revoked approval of monoclonal antibody bevacizumab (Avastin) for use in metastatic breast cancer.
Highlights of the article, by Andrew Pollack:

Pharmaceutical manufacturer Genentech plans another clinical trial to prove …

FDA Halts Hip Manufacturers

In an unusual move, the Food and Drug Administration has ordered all producers of a popular category of artificial hip to undertake studies of the implants, which have been linked to high early failure rates and severe health effects in …

FDA Endorses New Criteria for Lap Band

The United States Food and Drug Administration recently lowered the prerequisite body mass index from 35 to 30 (in patients with a comorbity) for use of Allergan’s Lap-Band ® Adjustable Gastric Banding System.  An article in Bariatric Times, authored by …